Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Treatment for Refractory H Pylori Infection
NCT02547025Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Aug 2012
- Primary completion
- Oct 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Open-label trial of rabeprazole, bismuth subcitrate, amoxicillin, clarithromycin, metronidazole and 2 more in Helicobacter pylori infection (3 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Number of Participants in Which H. Pylori Was Eradicated. Started Aug 2012; status: completed.
02
Drugs
rabeprazolebismuth subcitrateamoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02547025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02547025.